1. Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer. (February 2023) Authors: Chan, Arlene; Ruiz-Borrego, Manuel; Marx, Gavin; Chien, A. Jo; Rugo, Hope S.; Brufsky, Adam; Thirlwell, Michael; Trudeau, Maureen; Bose, Ron; García-Sáenz, José A.; Egle, Daniel; Pistilli, Barbara; Wassermann, Johanna; Cheong, Kerry A.; Schnappauf, Benjamin; Semsek, Dieter; Singer, Christian F.; ... Journal: Breast Issue: Volume 67(2023) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗